KIMBERLY ALLEN: Open Payments
NPI 1568874998 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,177 in 45 payments from 16 companies in 2025. Trend: 2023 $479 · 2024 $410 · 2025 $1,177
Food & beverage: $1,177
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 3 | $164 |
| Ardelyx, Inc. | 5 | $138 |
| Gilead Sciences, Inc. | 1 | $112 |
| Axsome Therapeutics, Inc. | 4 | $106 |
| AstraZeneca Pharmaceuticals LP | 6 | $101 |
| Vanda Pharmaceuticals Inc. | 3 | $92 |
| Alkermes, Inc. | 5 | $85 |
| ABBVIE INC. | 4 | $80 |
| Lilly USA, LLC | 3 | $71 |
| Noven Therapeutics, LLC | 2 | $50 |
Products named: Omnipod, IBSRELA, Epclusa, Auvelity, FANAPT, ARISTADA, JARDIANCE, AIRSUPRA.
Industry payments across LA — which companies pay providers there.
